These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11522754)

  • 21. Deletion mapping of chromosome 16q in hepatocellular carcinoma.
    Piao Z; Park C; Kim JJ; Kim H
    Br J Cancer; 1999 May; 80(5-6):850-4. PubMed ID: 10360665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
    Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
    Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis.
    Kuroki T; Fujiwara Y; Tsuchiya E; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
    Genes Chromosomes Cancer; 1995 Jul; 13(3):163-7. PubMed ID: 7669735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.
    Wilkens L; Bredt M; Flemming P; Kubicka S; Klempnauer J; Kreipe H
    Am J Clin Pathol; 2000 Dec; 114(6):867-74. PubMed ID: 11338475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.
    Cai YR; Gong L; Teng XY; Zhang HT; Wang CF; Wei GL; Guo L; Ding F; Liu ZH; Pan QJ; Su Q
    World J Gastroenterol; 2009 Oct; 15(37):4695-708. PubMed ID: 19787833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.
    Nishimura T; Nishida N; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Cancer Genet Cytogenet; 2006 May; 167(1):57-65. PubMed ID: 16682288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
    Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
    Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant.
    Pagano D; Barbera F; Conaldi PG; Seidita A; Di Francesco F; Di Carlo D; Bàrbara M; Tuzzolino F; Luca A; Gruttadauria S
    Ann Transplant; 2019 Apr; 24():223-233. PubMed ID: 31015392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion mapping of chromosome 4q in hepatocellular carcinoma.
    Piao Z; Park C; Park JH; Kim H
    Int J Cancer; 1998 Aug; 79(4):356-60. PubMed ID: 9699526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization.
    Terracciano L; Tornillo L
    Pathologica; 2003 Apr; 95(2):71-82. PubMed ID: 12768875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
    Zhang SH; Cong WM; Xian ZH; Wu MC
    World J Gastroenterol; 2005 May; 11(20):3034-9. PubMed ID: 15918185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production.
    Yeh SH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 1996 Jan; 110(1):184-92. PubMed ID: 8536855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules.
    Quagliata L; Andreozzi M; Kovac M; Tornillo L; Makowska Z; Moretti F; Heim MH; Heinimann K; Piscuoglio S; Terracciano LM
    Eur J Cancer; 2014 Mar; 50(4):731-8. PubMed ID: 24315626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.
    Hertz S; Rothämel T; Skawran B; Giere C; Steinemann D; Flemming P; Becker T; Flik J; Wiese B; Soudah B; Kreipe H; Schlegelberger B; Wilkens L
    Pathobiology; 2008; 75(5):312-22. PubMed ID: 18931534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
    Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
    Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of liver-cirrhosis nodules by analysis of gene-expression profiles and patterns of allelic loss.
    Nagai H; Terada Y; Tajiri T; Yabe A; Onda M; Nagahata T; Ezura Y; Minegishi M; Horiguchi M; Baba M; Konishi N; Emi M
    J Hum Genet; 2004; 49(5):246-55. PubMed ID: 15362568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic changes and histopathological grades in human hepatocellular carcinomas.
    Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
    Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RADS) categories and features.
    Furlan A; Almusa O; Yu RK; Sagreiya H; Borhani AA; Bae KT; Marsh JW
    Br J Radiol; 2018 Jun; 91(1086):20170962. PubMed ID: 29565672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: correlation with HBV and HCV infections and cellular proliferation rate.
    Gramantieri L; Trerè D; Pession A; Piscaglia F; Masi L; Gaiani S; Mazziotti A; Bolondi L
    Dig Dis Sci; 2000 Feb; 45(2):306-11. PubMed ID: 10711443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
    Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ
    Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.